Physician profile

Taylor Smith Harris

Primary Care · Burlington, NC

NPI 1467020552

$692.53

in general payments reported to CMS, 2019-2025

18 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $91.31 2021-2022
Lilly USA, LLC $65.60 2021-2022
Biohaven Pharmaceuticals, INC. $59.73 2021
Merck Sharp & Dohme LLC $56.30 2021-2022
Novo Nordisk INC $50.94 2021-2022
Mallinckrodt Hospital Products INC. $49.54 2021-2022
Amgen INC. $44.37 2021-2022
Astrazeneca Pharmaceuticals Lp $40.26 2021-2022
Insulet Corporation $36.48 2022
Baxter Healthcare $33.78 2022
Takeda Pharmaceuticals U.S.A., INC. $33.37 2021
Amarin Pharma, INC. $32.65 2021-2022
Boehringer Ingelheim Pharmaceuticals, INC. $23.09 2022
Exeltis, USA INC. $19.11 2022
Medtronic, INC. $15.55 2022
Show all 18 companies
CompanyGeneral paymentsYearsTop products
Mylan Specialty L.P. $15.08 2021
Arthrex, INC. $13.80 2022
Glaxosmithkline, LLC. $11.57 2021

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Taylor Smith Harris

$692.53

in general payments reported 2019-2025

Years
2021-2022
Top company
Abbvie INC.

https://glasscript.com/doctor/10694652/taylor-smith-harris

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.